Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 equivalence and safety study of 5% minoxidil foam versus Men's Rogaine in adult men with androgenetic alopecia
CTR20244180Phase 3Active
- Sponsor
- Guangdong Red Coral Pharmaceutical
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by Guangdong Red Coral Pharmaceutical. Started Jan 2025; status: active.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on CTR20244180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244180.